Literature DB >> 20798248

Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element.

Gil Arvatz1, Uri Barash, Ofer Nativ, Neta Ilan, Israel Vlodavsky.   

Abstract

Heparanase up-regulation was documented in an increasing number of human carcinomas, associated with poor prognosis. The purpose of the current study was to identify mechanisms responsible for heparanase induction. We provide evidence that heparanase expression is regulated at the post-transcriptional level by sequences at the 3' untranslated region (3' UTR) of the gene. Constructing the 3' UTR immediately following the heparanase cDNA reduces heparanase enzymatic activity and protein levels, resulting in decreased cellular invasion capacity. We further identified a 185-bp sequence within the 3' UTR that mediates heparanase down-regulation, and characterized an adenine (A)/uracil (U)-rich consensus element (ARE) within this region. Deletion of the entire 185-bp region or the ARE eliminated the inhibitory effect of the 3' UTR, resulting in elevated heparanase levels and formation of larger tumor xenografts indistinguishable from those produced by heparanase-overexpressing cells in terms of size, vascularization, and Akt activation. These results suggest that loss of the ARE is an important regulatory mechanism contributing to heparanase induction in human cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798248      PMCID: PMC3229425          DOI: 10.1096/fj.10-156372

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  40 in total

1.  Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.

Authors:  Masahiro Aoki; Hao Jiang; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

Review 2.  Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins.

Authors:  Peter K Vogt; Hao Jiang; Masahiro Aoki
Journal:  Cell Cycle       Date:  2005-07-03       Impact factor: 4.534

3.  Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.

Authors:  Tatsuya Ogishima; Hiroaki Shiina; Julia E Breault; Masaharu Terashima; Satoshi Honda; Hideki Enokida; Shinji Urakami; Takashi Tokizane; Toshifumi Kawakami; Leopoldo A Ribeiro-Filho; Makoto Fujime; Christopher J Kane; Peter R Carroll; Mikio Igawa; Rajvir Dahiya
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

4.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

5.  Heparanase promotes growth, angiogenesis and survival of primary breast tumors.

Authors:  Irit Cohen; Orit Pappo; Michael Elkin; Tamara San; Rachel Bar-Shavit; Rachel Hazan; Tamar Peretz; Israel Vlodavsky; Rinat Abramovitch
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

6.  Human heparanase. Purification, characterization, cloning, and expression.

Authors:  M Toyoshima; M Nakajima
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

7.  Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.

Authors:  Anna Zetser; Yulia Bashenko; Evgeny Edovitsky; Flonia Levy-Adam; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

8.  Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.

Authors:  Tatsuya Ogishima; Hiroaki Shiina; Julia E Breault; Laura Tabatabai; William W Bassett; Hideki Enokida; Long-Cheng Li; Toshifumi Kawakami; Shinji Urakami; Leopoldo A Ribeiro-Filho; Masaharu Terashima; Makoto Fujime; Mikio Igawa; Rajvir Dahiya
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

9.  Subcellular localization of human heparanase and its alternative splice variant in COS-7 cells.

Authors:  Mayumi Sato; Kana Amemiya; Sumio Hayakawa; Hiroshi Munakata
Journal:  Cell Biochem Funct       Date:  2008-08       Impact factor: 3.685

Review 10.  AU-rich elements and associated factors: are there unifying principles?

Authors:  Carine Barreau; Luc Paillard; H Beverley Osborne
Journal:  Nucleic Acids Res       Date:  2006-01-03       Impact factor: 16.971

View more
  17 in total

1.  Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.

Authors:  Marina Weissmann; Gil Arvatz; Netanel Horowitz; Sari Feld; Inna Naroditsky; Yi Zhang; Mary Ng; Edward Hammond; Eviatar Nevo; Israel Vlodavsky; Neta Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

2.  Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.

Authors:  Uri Barash; Moshe Lapidot; Yaniv Zohar; Cynthia Loomis; Andre Moreira; Sari Feld; Chandra Goparaju; Haining Yang; Edward Hammond; Ganlin Zhang; Jin-Ping Li; Neta Ilan; Arnon Nagler; Harvey I Pass; Israel Vlodavsky
Journal:  J Natl Cancer Inst       Date:  2018-10-01       Impact factor: 13.506

Review 3.  Heparanase: From basic research to therapeutic applications in cancer and inflammation.

Authors:  Israel Vlodavsky; Preeti Singh; Ilanit Boyango; Lilach Gutter-Kapon; Michael Elkin; Ralph D Sanderson; Neta Ilan
Journal:  Drug Resist Updat       Date:  2016-10-06       Impact factor: 18.500

Review 4.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

Review 5.  Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

Authors:  Israel Vlodavsky; Miriam Gross-Cohen; Marina Weissmann; Neta Ilan; Ralph D Sanderson
Journal:  Trends Biochem Sci       Date:  2017-11-20       Impact factor: 13.807

6.  Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy.

Authors:  Anna Shteingauz; Ilanit Boyango; Inna Naroditsky; Edward Hammond; Maayan Gruber; Ilana Doweck; Neta Ilan; Israel Vlodavsky
Journal:  Cancer Res       Date:  2015-08-06       Impact factor: 12.701

7.  Heparanase cooperates with Ras to drive breast and skin tumorigenesis.

Authors:  Ilanit Boyango; Uri Barash; Inna Naroditsky; Jin-Ping Li; Edward Hammond; Neta Ilan; Israel Vlodavsky
Journal:  Cancer Res       Date:  2014-06-26       Impact factor: 12.701

8.  Heparanase enhances myeloma progression via CXCL10 downregulation.

Authors:  U Barash; Y Zohar; G Wildbaum; K Beider; A Nagler; N Karin; N Ilan; I Vlodavsky
Journal:  Leukemia       Date:  2014-04-04       Impact factor: 11.528

9.  Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.

Authors:  Iván Fernández-Vega; Olivia García; Ainara Crespo; Sonia Castañón; Primitiva Menéndez; Aurora Astudillo; Luis M Quirós
Journal:  BMC Cancer       Date:  2013-01-17       Impact factor: 4.430

10.  Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade.

Authors:  Olivia García-Suárez; Beatriz García; Iván Fernández-Vega; Aurora Astudillo; Luis M Quirós
Journal:  Front Oncol       Date:  2014-02-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.